Ajanta Pharma Buyback 2022 Record Date, Buyback Price & Details

Ajanta Pharma (NSE: AJANTPHARM, BSE: 532331) buyback 2022 was announced on 28 December 2021. The buyback record date is 14 January 2022. Ajanta Pharma Limited is a multinational company engaged in the development, manufacturing, and marketing of pharmaceutical formulations. They have a presence in India, the United States, Africa, South East Asia, West Asia, and CIS. The company was established in 1973. Ajanta Pharma reported revenue of 2,916 crores in 2022-2021. The company has over 7000 employees working globally. They have 7 manufacturing facilities in India. They have designed a customized basket of products for each of these markets and serve a wide range of therapeutic segments like Anti-Biotic, Anti-Malarial, Anti-Diabetic, Cardiology, Gynecology, Orthopedics, Pediatric, Respiratory & General Health products.

Ajanta Pharma Buyback 2022 Offer Details:

Ajanta Pharma buyback of 11,20,000 equity shares that are around 1.29% of all the existing number of equity shares at a price of ₹2550 per equity share. The buyback offers not to exceed ₹285.60 crores of the total buyback offer size.

Ajanta Pharma Financial Report:

Ajanta Pharma Buyback Eligible Share Holders:

The investors are eligible for the buyback scheme who have Ajanta Pharma shares in their Demat account as the record date is 14 January 2022. Investors can participate in the Ajanta Pharma Buyback 2022 scheme as per the opening form by selling their shares. The payment will be given as per the accepted shares by the company under the Ajanta Pharma buyback scheme.

Ajanta Pharma Company Address

Ajanta Pharma Buyback 2022 FAQs:

Note: If anything you want to know about the buyback offer you can refer to the Ajanta Pharma buyback offer documents.